S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI
2020-02	PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation Min, Ahrum; Im, Seock-Ah Cancers, Vol.12 No.2, p. 394	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-07	Homologous repair deficiency score for identifying breast cancers with defective DNA damage response Min, Ahrum; Kim, Kwangsoo; Jeong, Kyeonghun; Choi, Seongmin; Kim, Seongyeong; Suh, Koung Jin; Lee, Kyung-Hun; Kim, Sun; Im, Seock-Ah Scientific Reports, Vol.10 No.1, p. 12506	DOI